1. Matskeplishvili ST, Potievskaya VI, Popovkina OE, et al. Cardiovascular complications of oncology treatment (cardiooncology): prevention, diagnosis, treatment — the consensus of experts.Technologies of living systems. 2018;15(6):3-35. (In Russ.) doi:10.18127/j20700997-201806-01.
2. 2016 ESC position paper on cancer treatments and cardiovascular 13. toxicity developed under the auspices of the ESC committee for practice guidelines. Russ J Cardiol. 2017;(3):105-139. (In Russ.) doi: 10.15829/1560-4071-2017-3-105-139.
3. Krikunova OV, Vasyuk YA, Viskov RV, et al. Chemotherapy cardiotoxicity screening with cardiac troponins. Russian J Cardiol. 2015;(12):119-25. (In Russ.) doi:10.15829/1560-4071-2015-12-119-125.
4. Balluzek MF, Ionova AK. Cardio-oncology in treatment and rehabilitation programs of oncological patients. Russian J Cardiol. 2014;(5):75-80. (In Russ.) doi:10.15829/1560-4071-2014-5-75-80.
5. Snegovoj AV, Vicenya MV, Kopp MV, Larionova VB. Practice guidelines on correction of cardiovascular toxicity induced by chemotherapy and targeted agents. Zlokachestvennye opukholi. 2016;418-27 (In Russ.) doi:10.18027/2224-5057-2016-4s2-418-427.